Cadila Pharmaceuticals launched the world's first aqueous Vitamin D injection, a water-based cholecalciferol formulation, promising to revolutionize Vitamin D deficiency treatment. The condition affects nearly 1 billion people globally. This new injection offers a significant improvement over existing oil-based versions, promising faster correction of the deficiency.